Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol 2008; 51:1237–1246.
Grundy SM, Cleeman JI, Daniels SR, et al Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735–2752.
Danesh J, Wheeler JG, Hirschfield GM, et al C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387–1397.
Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374–381.
Björntorp P, Rosmond R. The metabolic syndrome: a neuroendocrine disorder? Br J Nutr 2000; 83( suppl 1):S49–S57.
Resnick HE, Howard BV. Diabetes and cardiovascular disease. Annu Rev Med 2002; 53:245–267.
Mandle CL, Jacobs SC, Arcari PM, Domar AD. The efficacy of relaxation response interventions with adult patients: a review of the literature. J Cardiovasc Nurs 1996; 10:4–26.
Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996; 156:745–752.
Ornish D, Scherwitz LW, Billings JH, et al Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280:2001–2007.
Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45:637–651.
Tracey KJ. The inflammatory reflex. Nature 2002; 420:853–859.

Effect of stress reduction using the BREATHE technique on inflammatory markers and risk factors for atherosclerosis